Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy

Table 1

Baseline characteristics, surgical procedures, and postoperative complications and additional treatments in the two groups.

	TME	nTME
Baseline general conditions
Eyes	56	60
Mean age (year)	57.8 ± 9.5 [38–74]	58.7 ± 14.1 [30–81]	0.20
Sex (male/female)	36/20	36/24	0.63
Diabetic duration (years)	12.4 ± 11.7 [1–41]	10.6 ± 9.2 [1–46]	0.38
HbA1c (%)	7.6 ± 1.7 [5.3–13.3]	7.9 ± 1.5 [4.8–11.8]	0.26
eGFR (ml/m)	54.9 ± 33.0 [0.5–112]	58.8 ± 36.8 [0.5–111]	0.25
Hypertension	34	43	0.21
Anticoagulant use	7	4	0.45
Baseline ocular conditions
Mean LogMAR	1.05 ± 0.71 [2.7–0]	1.26 ± 0.74 [2.7–0.05]	0.06
Mean CMT (μm)	467 ± 200 [150–1008]	410 ± 133 [148–998]	0.06
Lens status (IOL/phakia)	3/53	10/50	0.10
Ocular hypertension	4	1	0.32
Vitreous hemorrhage	31	52	<0.001
Tractional retinal detachment	11	5	0.13
Adjunctive intravitreal anti-VEGF injection	16	11	0.19
Retinal photocoagulation	39	46	0.39
Surgical procedures
Combined cataract surgery	49	36	<0.001
Retinal break	17	9	0.079
Tamponade (air/gas/silicon oil)	18/8/1	16/6/0	0.54
Postoperative complications and additional treatments
Vitreous hemorrhage	13	14	0.99
Neovascular glaucoma	2	4	0.40
Cataract progression	1	4	0.21
Revitrectomy	8	5	0.47
Intravitreal anti-VEGF injection	2	4	0.74
Subtenon steroid injection	10	3	0.057

Data are expressed as number of eyes or patients or mean ± standard deviation [low–high].